|
Novel ASO therapeutic targeting CCDC146, a newly identified driver of motor neuron degeneration in ALS
Demonstrated efficacy across both sporadic and familial ALS models, supporting broad patient applicability
Improves motor function, neuronal survival, and lifespan in preclinical ALS models
Abstract
USC researchers have developed a targeted antisense...
|